TWN Info Service on Biosafety
18 March 2026
Third World Network
www.twn.my
Dear Friends and Colleagues
Genome editing outside of controlled facilities poses grave risks
A new mini-review rebuts denials of the existence, and concomitant risks of, emerging genetic engineering and synthetic biology technologies that are enabling uncontained ‘outdoor genome editing’.
The article summarises advances in genome editing applications, including products, patents, and research studies, that show at-scale outdoor deployment outside of containment and controlled facilities is “approaching feasibility”. The uncontrolled release of genome editors is “not just hypothetical”. As the article illuminates, genome editing kits have already been sold, packaged inside yeast. Regulatory approvals are also advancing for LMO bacteria that deliver genome editors to other microbial species. Viruses have been developed to expressed genome editors with the intention to be released onto crop plants to modify them.
Research also demonstrates advances in delivering genome editors alone, without being packaged inside a living organism. For example, the recent demonstration of functional delivery of genome editors to mammalian guts reported survival in the harsh digestive environment, aided by the use of nanoparticles. Formulation ingredients and other biological and chemical tools are revolutionising how genome editors, and other genetic technologies such as RNAi pesticides, are delivered to organisms. With the aid of nanoparticles and other co-formulants to protect and stabilise the genome editing proteins from harsh environments, genome editor delivery routes are expanding in possibilities.
Such applications would risk exposing non-target organisms to genetic engineering machinery, and thus be potentially unintentionally engineered in the open environment. This paradigm shift in genome editing application raises serious biosafety concerns. It also creates key challenges for current risk assessment frameworks that were envisaged for assessing the engineering of intended organisms in controlled environments, where they can at least, in theory, be assessed for safety prior to release.
As the article illustrates, horizon-scanning and foresight is vital to staying abreast of potential risks of novel biotechnology applications to biodiversity, and human health. They conclude: “The use of genome editing outside of controlled facilities is imagined worldwide and expressed in peer-reviewed literature, patents, and respected science adjacent publications. Scalable lab-free genome editing is already firmly in the technological trajectory of molecular biology and agricultural practice. It is time to turn the discussion from denial to guidance for safe and responsible use.”
With best wishes,
Third World Network
———————————————————————————————–
Genome editing outside of controlled facilities: A review of plausible futures and risks
Heinemann JA, Hiscox TC, Zanatta CB, Kurenbach B, Walker S, McCabe AW, Hoepers AM, Agapito-Tenfen SZ (2026). Ecotoxicol Environ Saf. https://doi.org/10.1016/j.ecoenv.2025.119565
Highlights
- We review rapid advances in delivery of genome editors to cells.
- Our focus is on using genome editing in vivo and in situ outside of laboratories.
- Some scientists deny these advances and a need for risk assessment.
- We provide a definitive bibliography to rebut their claims.
- We discuss important hazard and exposure considerations in risk assessment.
Abstract
Vectors for delivering proteins and/or nucleic acids into the cells of whole organisms, from single to multicellular, are rapidly advancing. Common cargos are nucleic acids needed to express the components of a genome editing reaction, or ribonucleoproteins (RNP) that can act immediately upon delivery. In only 20 years, improvements in associated formulation technologies have decreased the dependence of genome editing on the need for a laboratory or trained personnel, allowing for genome editing outside of controlled facilities. As this happens, both target and non-target organisms may be exposed to active biological agents, necessitating a new framework for risk assessment. Some scientists deny developments for gene editing in uncontrolled environments, leading to scientifically unjustified dismissals of risk.